2,380 Shares in Cigna Group $CI Acquired by First National Bank of Omaha

First National Bank of Omaha acquired a new stake in shares of Cigna Group (NYSE:CIFree Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,380 shares of the health services provider’s stock, valued at approximately $686,000.

Several other large investors also recently modified their holdings of CI. Massachusetts Financial Services Co. MA increased its position in Cigna Group by 1.1% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after purchasing an additional 123,479 shares during the period. Dodge & Cox boosted its stake in shares of Cigna Group by 0.7% during the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock valued at $2,958,893,000 after purchasing an additional 60,877 shares in the last quarter. Norges Bank purchased a new position in shares of Cigna Group during the second quarter valued at about $1,110,426,000. Arrowstreet Capital Limited Partnership raised its stake in Cigna Group by 24.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after buying an additional 492,045 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Cigna Group by 0.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock worth $678,652,000 after buying an additional 15,014 shares during the period. 86.99% of the stock is owned by institutional investors.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $285.92 on Friday. The stock has a market cap of $76.38 billion, a P/E ratio of 12.89, a P/E/G ratio of 1.01 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74. The stock’s fifty day moving average is $278.79 and its 200 day moving average is $284.00. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same quarter last year, the business earned $6.64 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.2%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is 27.23%.

Wall Street Analyst Weigh In

CI has been the subject of several recent research reports. The Goldman Sachs Group lowered their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research report on Tuesday, November 4th. Guggenheim reissued a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a research note on Monday, February 2nd. Wells Fargo & Company cut their price objective on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Robert W. Baird cut their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $330.63.

Check Out Our Latest Stock Report on Cigna Group

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.